Biaxin News

Advanced Life Sciences Holdings Reports Effective Results From CL ... - RTT News

According to the results, cethromycin cured 94.0% of patients with CAP, compared to Biaxin, a current standard of care treatment for CAP, which cured 93.8% ...

Posted: Thu Nov 15 14:35:11 -0500 2007

ADLS: Positive Ph III Trial for Oral Antibiotic vs Abbott's Biaxin ... - Trading Markets (press release)

The study results showed that cethromycin cured 94.0% of patients with CAP, compared to Abbott's (ABT) Biaxin(R) (clarithromycin), a current standard of ...

Posted: Thu Nov 15 11:03:32 -0500 2007

JC Penney, Barclays Shed Value - Wall Street Journal

... or 25.8%, to 2.39 after the company said its pneumonia treatment, cethromycin, performed better than the standard Biaxin treatment in a Phase III trial. ...

Posted: Thu Nov 15 09:49:13 -0500 2007

Thursday's Health Winners & Losers - TheStreet.com

The study results showed that cethromycin was non-inferior to Biaxin, a current standard-of-care treatment for CAP, and demonstrated favorable safety ...

http://www.thestreet.com/s/thursd... | Posted: Thu Nov 15 15:19:50 -0500 2007

Cethromycin achieves all endpoints in second pivotal Phase III ... - EurekAlert (press release)

The study results showed that cethromycin cured 94.0% of patients with CAP, compared to Biaxin® (clarithromycin), a current standard of care treatment for ...

Posted: Thu Nov 15 09:36:31 -0500 2007

Advanced Life Sciences' new drug revives stock - Chicago Sun-Times

all 29 news articles

Posted: Thu Nov 15 13:23:11 -0500 2007

Abbott Laboratories Ratings Affirmed; Pending $3 Billion Notes ... - PharmaLive.com (press release)

The promise of new products and strong growth of leading products over shadows the loss of patent protection for antibiotics Biaxin and Omnicef, ...

Posted: Wed Nov 07 10:23:54 -0500 2007

Ranbaxy recieves USFDA approval for anti-bacterial drug - Hindu

Clarithromycin for Oral Suspension, USP is a generic version of Abbott Laboratories Biaxin Granules. USFDA determined the Ranbaxy's formulation to be ...

http://www.hindu.com/thehindu/hol... | Posted: Fri Oct 05 03:58:54 -0400 2007

INDIA'S RANBAXY GETS USFDA NOD FOR ANTI-INFECTION DRUG - Trading Markets (press release)

As per the USFDA, the Ranbaxy formulation is bio-equivalent and has the same therapeutic effect as that of the reference listed drug Biaxin Granules in the ...

http://www.tradingmarkets.com/.si... | Posted: Thu Oct 04 02:47:20 -0400 2007